Desensitization for immediate hypersensitivity to oral dimethyl fumarate (Tecfidera)

J Allergy Clin Immunol Pract. 2017 May-Jun;5(3):821-822. doi: 10.1016/j.jaip.2016.09.044. Epub 2016 Nov 23.

Authors

Danilo Di Bona¹, Marcello Albanesi², Lucia A Giliberti², Andrea Nico², Maria Pia Rossi², Maria Filomena Caiaffa³, Luigi Macchia²

Affiliations

¹ Department of Emergency and Organ Transplantation, School of Allergology and Clinical Immunology, University of Bari Aldo Moro, Bari, Italy. Electronic address: danilo.dibona@uniba.it.
² Department of Emergency and Organ Transplantation, School of Allergology and Clinical Immunology, University of Bari Aldo Moro, Bari, Italy.
³ Department of Medical and Surgical Sciences, School of Allergology and Clinical Immunology, University of Foggia, Fooggia, Italy.

PMID: 27888036
DOI: 10.1016/j.jaip.2016.09.044

No abstract available

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Administration, Oral
Allergens / immunology*
Allergens / therapeutic use
Combined Modality Therapy
Desensitization, Immunologic / methods*
Dimethyl Fumarate / immunology*
Dimethyl Fumarate / therapeutic use
Drug Hypersensitivity / immunology
Drug Hypersensitivity / therapy*
Female
Histamine Antagonists / therapeutic use
Humans
Hypersensitivity, Immediate / immunology
Hypersensitivity, Immediate / therapy*
Immunosuppressive Agents / immunology*
Immunosuppressive Agents / therapeutic use
Middle Aged
Multiple Sclerosis, Relapsing-Remitting / drug therapy*
Pruritus
Urticaria

Substances

Allergens
Histamine Antagonists
Immunosuppressive Agents
Dimethyl Fumarate